Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read.
In "Moderna Reports More Promising Data on Cancer Treatment. The Stock Jumps," Josh Nathan-Kazis writes that Moderna Inc (NASDAQ:MRNA)
shared good news about their cancer treatment trial, suggesting better chances of survival when using their therapy alongside Merck's Keytruda.
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo: Shutterstock
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
